BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Lorenzo M, Palau P, Llàcer P, Domínguez E, Ventura B, Núñez G, Miñana G, Solsona J, Santas E, De La Espriella R, Bodí V, Núñez E, Sanchis J, Bayés-Genís A, Núñez J. Clinical utility of antigen carbohydrate 125 for planning the optimal length of stay in acute heart failure. Eur J Intern Med 2021:S0953-6205(21)00196-5. [PMID: 34130879 DOI: 10.1016/j.ejim.2021.05.037] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Miñana G, de la Espriella R, Palau P, Llácer P, Núñez E, Santas E, Valero E, Lorenzo M, Núñez G, Bodí V, Heredia R, Sanchis J, Bayés-Genís A, Chorro FJ, Núñez J. Carbohydrate antigen 125 and risk of heart failure readmissions in patients with heart failure and preserved ejection fraction. Sci Rep 2022;12:1344. [PMID: 35079082 DOI: 10.1038/s41598-022-05328-2] [Reference Citation Analysis]
2 de la Espriella R, Bayés-Genís A, Llàcer P, Palau P, Miñana G, Santas E, Pellicer M, González M, Górriz JL, Bodi V, Sanchis J, Núñez J. Prognostic value of NT-proBNP and CA125 across glomerular filtration rate categories in acute heart failure. Eur J Intern Med 2021:S0953-6205(21)00297-1. [PMID: 34507853 DOI: 10.1016/j.ejim.2021.08.024] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]